Files
statdx/docs_md/articles/creutzfeldt-jakob-disease-cjd_e1b27954-6591-4bb0-a659-b13790492620.md
Ross 9c86b32c3b .
2025-10-20 21:15:33 +01:00

49 KiB

title, docid, authors, breadcrumbs, category, cmeTopicId, documentVersionId, imageCount, lastUpdated, pageDescription, pageKeywords, pageTitle, enhancedTitle, type, references, tables, breadcrumbs
title docid authors breadcrumbs category cmeTopicId documentVersionId imageCount lastUpdated pageDescription pageKeywords pageTitle enhancedTitle type references tables breadcrumbs
Creutzfeldt-Jakob Disease (CJD) e1b27954-6591-4bb0-a659-b13790492620
key value
1fa14dfd-71ea-4960-908e-e720313bc63a Santhosh Gaddikeri, MD
key value
a25c450b-3d34-4f64-bba3-cc0834813df6 Miral D. Jhaveri, MD, MBA
name slug treeNodeId
Brain brain 6d8829f1-14d7-45af-8675-255189aa526a
name slug treeNodeId
Diagnosis diagnosis 51c00394-446e-4a38-94af-d3b1d14d34e8
name slug treeNodeId
Pathology-Based Diagnoses pathology-based-diagnoses d9d3a8ed-f21b-4831-8c77-591a3500ef77
name slug treeNodeId
Acquired Toxic/Metabolic/Degenerative Disorders acquired-toxicmetabolicdegenerativ- ba3cfeaf-64d9-4117-91e8-d2ce58783fc5
name slug treeNodeId
Dementias and Degenerative Disorders dementias-and-degenerative-disorde- 6381104d-7a4c-4be5-bb19-3cd90837d547
name slug treeNodeId
Creutzfeldt-Jakob Disease (CJD) creutzfeldt-jakob-disease-cjd null
Brain c8f04e6d-7d9d-454a-9aac-87b367f8ea27 84bd6102-ccba-4290-82a7-d66525e3c7b2 23 09/30/20 Creutzfeldt-Jakob Disease (CJD) Brain, Diagnosis, Pathology-Based Diagnoses, Acquired Toxic/Metabolic/Degenerative Disorders, Dementias and Degenerative Disorders, Creutzfeldt-Jakob Disease (CJD) Creutzfeldt-Jakob Disease (CJD) | STATdx Creutzfeldt-Jakob Disease (CJD) DX true 1
Brain
Diagnosis
Pathology-Based Diagnoses
Acquired Toxic/Metabolic/Degenerative Disorders
Dementias and Degenerative Disorders
Creutzfeldt-Jakob Disease (CJD)

title: "Creutzfeldt-Jakob Disease (CJD)" docid: "e1b27954-6591-4bb0-a659-b13790492620" authors:

  • key: "1fa14dfd-71ea-4960-908e-e720313bc63a" value: "Santhosh Gaddikeri, MD"
  • key: "a25c450b-3d34-4f64-bba3-cc0834813df6" value: "Miral D. Jhaveri, MD, MBA" breadcrumbs:
  • name: "Brain" slug: "brain" treeNodeId: "6d8829f1-14d7-45af-8675-255189aa526a"
  • name: "Diagnosis" slug: "diagnosis" treeNodeId: "51c00394-446e-4a38-94af-d3b1d14d34e8"
  • name: "Pathology-Based Diagnoses" slug: "pathology-based-diagnoses" treeNodeId: "d9d3a8ed-f21b-4831-8c77-591a3500ef77"
  • name: "Acquired Toxic/Metabolic/Degenerative Disorders" slug: "acquired-toxicmetabolicdegenerativ-" treeNodeId: "ba3cfeaf-64d9-4117-91e8-d2ce58783fc5"
  • name: "Dementias and Degenerative Disorders" slug: "dementias-and-degenerative-disorde-" treeNodeId: "6381104d-7a4c-4be5-bb19-3cd90837d547"
  • name: "Creutzfeldt-Jakob Disease (CJD)" slug: "creutzfeldt-jakob-disease-cjd" treeNodeId: null category: "Brain" cmeTopicId: "c8f04e6d-7d9d-454a-9aac-87b367f8ea27" documentVersionId: "84bd6102-ccba-4290-82a7-d66525e3c7b2" imageCount: 23 lastUpdated: "09/30/20" pageDescription: "Creutzfeldt-Jakob Disease (CJD)" pageKeywords: "Brain, Diagnosis, Pathology-Based Diagnoses, Acquired Toxic/Metabolic/Degenerative Disorders, Dementias and Degenerative Disorders, Creutzfeldt-Jakob Disease (CJD)" pageTitle: "Creutzfeldt-Jakob Disease (CJD) | STATdx" enhancedTitle: "Creutzfeldt-Jakob Disease (CJD)" type: "DX" references: true tables: 1 breadcrumbs:
  • "Brain"
  • "Diagnosis"
  • "Pathology-Based Diagnoses"
  • "Acquired Toxic/Metabolic/Degenerative Disorders"
  • "Dementias and Degenerative Disorders"
  • "Creutzfeldt-Jakob Disease (CJD)"

KEY FACTS

  • Terminology

    • Creutzfeldt-Jakob disease (CJD): Rapidly progressing, fatal, potentially transmissible dementia caused by prion
  • Imaging

    • Best imaging clue: Progressive DWI/FLAIR hyperintensity of basal ganglia (BG), thalamus, and cerebral cortex
    • Predominantly gray matter (GM): Caudate and putamen > globus pallidus (GP) - Thalamus: Common in variant CJD (vCJD) - Cerebral cortex: Frontal, parietal, and temporal
    • Heidenhain variant: Occipital lobe
    • 2 signs seen in 90% of vCJD but can also occur in sporadic CJD (sCJD) - Pulvinar sign: Symmetric T2 hyperintensity of pulvinar of thalamus - Hockey stick sign: Symmetric pulvinar and dorsomedial thalamic nuclear hyperintensity
    • Best imaging tool: MR with DWI
  • Top Differential Diagnoses

    • Hypoxic-ischemic injury
    • Osmotic demyelination syndrome
    • Other causes of dementia - Alzheimer, frontotemporal, and multiinfarct dementia; dementia in motor neuron disease
    • Leigh syndrome
    • Corticobasal degeneration
  • Clinical Issues

    • Definite CJD diagnosed by neuropathology
    • Progressive dementia associated with myoclonic jerks and akinetic mutism; variable constellation of pyramidal, extrapyramidal, and cerebellar signs
    • CSF protein biomarkers: 14-3-3 protein, total tau (t-tau), S100 and neuron-specific enolase (NSE)
    • DWI MR has higher diagnostic accuracy, 97% more than any or all of these CSF biomarkers
    • Incidence 1 per 1,000,000 (USA and internationally) - sCJD (85%), familial (15%), infectious/iatrogenic (< 1%) (includes vCJD)
    • Death usually ensues within months of onset

TERMINOLOGY

  • Abbreviations

    • Creutzfeldt-Jakob disease (CJD)
    • Sporadic Creutzfeldt-Jakob disease (sCJD)
    • Variant Creutzfeldt-Jakob disease (vCJD)
  • Definitions

    • Rapidly progressing, fatal, neurodegenerative disorder caused by prion (proteinaceous infectious particle devoid of DNA and RNA) - Transmissible spongiform encephalopathy

IMAGING

  • General Features

    • Best diagnostic clue

      - Progressive T2 hyperintensity of basal ganglia (BG), thalamus, and cerebral cortex
      
    • Location

      - Predominantly gray matter (GM)
              - BG: Caudate and putamen > globus pallidus (GP)
              - Thalamus (common in vCJD)
              - Cerebral cortex (most commonly frontal, parietal, and temporal lobes)
                        - Cortical involvement often asymmetric
                        - Heidenhain variant: Occipital lobe
                        - Brownell-Oppenheimer: Cerebellum
      - May involve only peripheral cortex
              - Cortical involvement often asymmetric
              - Primary sensorimotor cortex relatively spared
      - White matter (WM) usually not involved
      
    • Size: Slight decrease (atrophy)

    • Morphology: Hyperintense T2 signal conforms to outline of BG and gyriform pattern in cortex

  • CT Findings

    • NECT: Usually normal - May show rapidly progressive atrophy and ventricular dilatation on serial CT - Serial CT illustrates atrophy progression
  • MR Findings

    • T1WI

      - Normal
      - GP hyperintensity reported in sCJD
      
    • T2WI

      - Hyperintense signal in BG, thalami, cortex
      - Cerebral atrophy
      - With time, hyperintense foci may develop in WM
      
    • FLAIR

      - 2 signs seen in 90% of vCJD but can also occur in sCJD
              - **Pulvinar**sign: Bilateral symmetrical hyperintensity of **pulvinar** (posterior) nuclei of **thalamus**
              - **Hockey stick** sign: Symmetrical **pulvinar and dorsomedial thalamic** nuclear hyperintensity
      - Periaqueductal GM hyperintensity
      - Cortical hyperintensity (common in sCJD)
      
    • DWI

      - Progressive hyperintensity in striatum and cortex
      - Gyriform hyperintense areas in cerebral cortex (cortical ribbon sign*)*
              - Correspond to localization of periodic sharp wave complexes on EEG
      - DWI hyperintensity may disappear late in disease
      
    • T1WI C+: No abnormal enhancement

  • Nuclear Medicine Findings

    • F-18 FDG PET: Regional glucose hypometabolism correlates with sites of neuropathologic lesions
    • SPECT with N-isopropyl-p-(I-123) iodoamphetamine (DaTSCAN) - ↓ uptake of tracer in BG reported - Sometimes in asymmetrical pattern
  • Imaging Recommendations

    • Best imaging tool: MR with DWI and FLAIR

DIFFERENTIAL DIAGNOSIS

PATHOLOGY

  • General Features

    • Etiology

      - Prion protein is misfolded isoform (PrPSc) of normal host-encoded protein (PrPc)
              - PrPSc = conformationally isomer of PrPc
      - PrPSc introduced into healthy cells → initiates self-perpetuating vicious cycle: PrPc → PrPSc → neurotoxicity
      - sCJD: Spontaneous PrPc → PrPSc or somatic mutation
      - Familial CJD (fCJD): Mutations in *PRNP*gene
      - Iatrogenic CJD: Infection from prion-containing material
              - Surgical instruments, dura mater grafts, stereotactic electrodes
              - Cadaveric corneal transplants, human pituitary hormones (growth hormone and gonadotropins)
      - vCJD: Bovine spongiform encephalopathy in cattle is transmitted to humans through infected beef
              - Primarily present in UK
              - a.k.a. new variant CJD (nvCJD)
      - Risk for health care workers
              - Physical contact with patients is no risk for transmission
              - Special precautions in handling brain tissue
              - All used materials and instruments decontaminated as per established protocols
      
    • Genetics

      - Can be inherited, sporadic, or acquired (infectious)
      - 10-15% of human prion disease cases associated with dominant mutations in autosomal prion protein (PrPc) gene (*PRNP*) on chromosome 20
      - PrPc is normal host protein on surface of many cells, particularly neurons
      
    • Associated abnormalities

      - EEG: Periodic (high-voltage) sharp wave complexes (PSWCs) on background of low-voltage activity
              - 67-95% patients with sCJD show PSWCs at some point during course of illness
              - False-positive EEG findings in Alzheimer dementia and vascular dementia patients
              - PSWCs helpful in differentiating sCJD from other prion disease
      
  • Staging, Grading, & Classification

    • Sporadic CJD - Definite - Characteristic neuropathology (biopsy or autopsy) - Protease-resistant PrPSc (PrPres) by Western blot - Probable - Neuropsychiatric disorder with positive RT-QuIC in CSF or other tissues - OR - Rapidly progressive dementia and at least 2 out of 4 clinical features listed in table 1 - AND positive result on at least 1 of 3 lab tests listed in table 1 - AND without routine investigations indicating alternative diagnosis - Possible - Progressive dementia and at least 2 out of 4 clinical features listed in table 1 - AND absence of positive lab tests that would classify case as "probable" - AND duration of illness < 2 years - AND without routine investigations indicating alternative diagnosis
    • Iatrogenic CJD: Progressive cerebellar syndrome in recipient of human cadaveric-derived pituitary hormone; or sporadic CJD with recognized exposure risk, e.g., antecedent neurosurgery with dura mater implantation
    • Familial CJD: Definite or probable CJD with definite or probable CJD in 1st-degree relative; &/or neuropsychiatric disorder with disease-specific PrP gene mutation
  • Gross Pathologic & Surgical Features

    • Mild cortical atrophy - Diffuse or confined to affected structures
    • Ventricular enlargement
  • Microscopic Features

    • Spongiform encephalopathy: GM most affected - Marked neuronal loss with reactive astrocytosis - Replacement gliosis - Neuronal vacuolation with spongiform changes
    • Spongiform panencephalopathy (very rare) - Primary extensive involvement of WM - Loss of myelin and axons associated with generalized spongiform change in WM - ± diffuse cerebral atrophy, loss of neurons, and proliferation of astrocytes in cerebral cortex
    • 10% of patients with CJD have amyloid plaques in cerebellum or cerebral hemispheres - Apple-green birefringence using Congo red staining when viewed under polarized light
    • Variable accumulation of PrPSc in brain tissue - PrPSc = abnormal, insoluble, protease-resistant amyloid form of PrPc - Diffuse (common in sCJD) or discrete plaques

CLINICAL ISSUES

  • Presentation

    • Most common signs/symptoms

      - Rapidly progressive dementia associated with myoclonic jerks and akinetic mutism
      - Variable constellation of pyramidal, extrapyramidal, and cerebellar signs
      
    • Clinical profile

      - **sCJD**: Cerebellar dysfunction, rapidly progressive cognitive impairment, both
              - 6 molecular subtypes: MM1, MM2 (thalamic and cortical), MV1, MV2, VV1, and VV2
                        - Vary with respect to age at onset, disease duration, early symptoms, and neuropathology
      - **vCJD**: Psychiatric and sensory symptoms
              - **Heidenhain variant** of CJD
                        - Isolated visual signs/symptoms (initially)
                        - Predominantly occipital lobe degeneration
                        - Normal conventional T1 and T2WI of brain
                        - DWI/FLAIR may detect early cortical abnormalities
              - **Brownell-Oppenheimer**: Cerebellar signs/symptoms
              - Extrapyramidal type of CJD
                        - May show ↑ signal intensity in BG
              - Pyramidal involvement with disease progression
              - BG dysfunction
              - Spinal cord involvement → muscle atrophy and fasciculations
      - **CSF studies**
              - CSF protein biomarkers: 14-3-3 protein, total tau (t-tau), S100, neuron-specific enolase (NSE), and thymosin β4
                        - 14-3-3 protein detection is adjunctive rather than diagnostic for prior disease
                        - t-tau > 1,150 picogram/mL has superior accuracy and specificity than 14-3-3 protein for CJD
                        - Significant false-positives and negatives with 14-3-3 and t-tau protein test results
              - DWI MR has higher diagnostic accuracy than any or all CSF biomarkers
      - Real-time quaking-induced conversion (RT-QUIC) testing of CSF to detected PrPsc
              - More sensitive using olfactory epithelium (nasal brushing) than CSF
              - Nasal brushing not performed in USA
      
  • Demographics

    • Age

      - Younger in vCJD, older in sCJD (6th-7th decades)
      
    • Sex

      - No sex preponderance
      
    • Ethnicity

      - sCJD occurs throughout world, in all races
      - In USA, CJD ↓ in Blacks, American Indians, and Alaskan natives than White population
      - vCJD limited to Europe (nearly all cases in UK)
      
    • Epidemiology

      - Incidence 1.0-1.5 per million in USA
      - sCJD (85-95%), familial (5-15%), infectious/iatrogenic (< 1%)
      
  • Natural History & Prognosis

    • Long incubation period but rapidly progressive once clinical symptoms begin
    • Rapidly progressing dementia with death usually ensuing within months of onset - Median survival from time of onset of symptoms to death is 4.5 months - 90% live < 1 year
  • Treatment

    • No effective treatment

DIAGNOSTIC CHECKLIST

  • Consider

    • Heidenhain variant of CJD in patients with visual disorders of unclear origin and dementia
  • Image Interpretation Pearls

    • Lack of BG findings does not rule out CJD

94600a52-3136-46e8-a827-05e281f28d7e

References

Selected References

  1. Alaoui A et al: [MRI role in Creutzfeldt-Jakob disease: about a case.] Pan Afr Med J. 32:95, 2019
  2. Baldwin KJ et al: Prion disease. Semin Neurol. 39(4):428-39, 2019
  3. Groveman BR et al: Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun. 7(1):12, 2019
  4. Hayashi Y et al: Clinicopathological findings of an MM2-cortical-type sporadic Creutzfeldt-Jakob disease patient with cortical blindness during a course of glaucoma and age-related macular degeneration. Prion. 13(1):124-31, 2019
  5. Llorens F et al: Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases. Neuropathol Appl Neurobiol. ePub, 2019
  6. Muniz BC et al: The Heidenhain variant of Creutzfeldt-Jakob disease. Radiol Bras. 52(3):199-200, 2019
  7. Xu Y et al: Sporadic Creutzfeldt-Jakob disease presenting as dizziness and cognitive decline: a case report. Medicine (Baltimore). 98(24):e16002, 2019
  8. Fragoso DC et al: Imaging of Creutzfeldt-Jakob disease: imaging patterns and their differential diagnosis. Radiographics. 37(1):234-57, 2017
  9. Koeller KK et al: Viral and prion infections of the central nervous system: radiologic-pathologic correlation: from the radiologic pathology archives. Radiographics. 37(1):199-233, 2017
  10. Caobelli F et al: The role of neuroimaging in evaluating patients affected by Creutzfeldt-Jakob disease: a systematic review of the literature. J Neuroimaging. 25(1):2-13, 2015
  11. Kim MO et al: Clinical update of Jakob-Creutzfeldt disease. Curr Opin Neurol. 28(3):302-10, 2015
  12. Felix-Morais R et al: Creutzfeldt-Jakob disease: typical imaging findings. BMJ Case Rep. 2014, 2014
  13. Risacher SL et al: Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol. 33(4):386-416, 2013
  14. Appleby BS et al: Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Arch Neurol. 66(2):208-15, 2009
  15. Iwasaki Y et al: Clinical diagnosis of Creutzfeldt-Jakob disease: accuracy based on analysis of autopsy-confirmed cases. J Neurol Sci. 277(1-2):119-23, 2009
  16. Josephs KA et al: Rapidly progressive neurodegenerative dementias. Arch Neurol. 66(2):201-7, 2009
  17. Manners DN et al: Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease. Neurology. 72(16):1425-31, 2009
  18. Meissner B et al: MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology. 72(23):1994-2001, 2009
  19. Clarençon F et al: MRI and FDG PET/CT findings in a case of probable Heidenhain variant Creutzfeldt-Jakob disease. J Neuroradiol. 35(4):240-3, 2008
  20. Fulbright RK et al: MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol. 29(9):1638-43, 2008
  21. Heinemann U et al: Brain biopsy in patients with suspected Creutzfeldt-Jakob disease. J Neurosurg. 109(4):735-41, 2008
  22. Meissner B et al: Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol. 29(8):1519-24, 2008
  23. Ward HJ et al: Risk factors for sporadic Creutzfeldt-Jakob disease. Ann Neurol. 63(3):347-54, 2008
  24. Yi SH et al: Relationship between clinical course and diffusion-weighted MRI findings in sporadic Creutzfeldt-Jakob Disease. Neurol Sci. 29(4):251-5, 2008
  25. Kallenberg K et al: Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. AJNR Am J Neuroradiol. 27(7):1459-62, 2006
  26. Lin YR et al: Creutzfeldt-jakob disease involvement of rolandic cortex: a quantitative apparent diffusion coefficient evaluation. AJNR Am J Neuroradiol. 27(8):1755-9, 2006
  27. Tschampa HJ et al: MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain. 128(Pt 9):2026-33, 2005
  28. Young GS et al: Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 26(6):1551-62, 2005
  29. Collins SJ et al: Transmissible spongiform encephalopathies. Lancet. 363(9402):51-61, 2004
  30. Summers DM et al: The pulvinar sign in variant Creutzfeldt-Jakob disease. Arch Neurol. 61(3):446-7, 2004

Tables

CDC Diagnostic Criteria for Creutzfeldt-Jakob Disease 2018

Clinical Features Lab Tests
Myoclonus Typical EEG (PSWCs)
Visual or cerebellar signs 14-3-3 CSF protein positive
Pyramidal/extrapyramidal signs DWI/FLAIR ↑ signal in caudate/putamen or at least 2 cortical regions (temporal, parietal, occipital)
Akinetic mutism

Images

Selected Images

A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction  and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres . A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres .

A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction  and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres . A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres .

A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction  and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres . A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres .

A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction  and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres . A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres .

A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction  and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres . A 53-year-old man with rapidly progressing cognitive decline due to sporadic Creutzfeldt-Jakob disease (sCJD) is shown. Axial DWI MR demonstrates symmetric bilateral basal ganglia (BG) diffusion restriction and asymmetric cortical restricted diffusion (cortical ribbon sign) in bilateral (right > > left) hemispheres .

Axial FLAIR MR in the same patient demonstrates hyperintense signal in bilateral BG  and cortex . CSF was positive for 14-3-3 protein indicating probable sCJD. Axial FLAIR MR in the same patient demonstrates hyperintense signal in bilateral BG and cortex . CSF was positive for 14-3-3 protein indicating probable sCJD.

Axial FLAIR MR in the same patient demonstrates hyperintense signal in bilateral BG  and cortex . CSF was positive for 14-3-3 protein indicating probable sCJD. Axial FLAIR MR in the same patient demonstrates hyperintense signal in bilateral BG and cortex . CSF was positive for 14-3-3 protein indicating probable sCJD.

Axial DWI MR in a patient with variant CJD (vCJD) demonstrates diffusion restriction in bilateral posteromedial aspect of thalami  representing hockey stick sign. Axial DWI MR in a patient with variant CJD (vCJD) demonstrates diffusion restriction in bilateral posteromedial aspect of thalami representing hockey stick sign.

Axial DWI MR in a patient with variant CJD (vCJD) demonstrates diffusion restriction in bilateral posteromedial aspect of thalami  representing hockey stick sign. Axial DWI MR in a patient with variant CJD (vCJD) demonstrates diffusion restriction in bilateral posteromedial aspect of thalami representing hockey stick sign.

Axial DWI MR in a different patient with vCJD shows diffusion restriction in bilateral posterior aspect of thalami in pulvinar region indicating pulvinar sign  . These signs are more common in vCJD but can occur in sporadic cases. Axial DWI MR in a different patient with vCJD shows diffusion restriction in bilateral posterior aspect of thalami in pulvinar region indicating pulvinar sign . These signs are more common in vCJD but can occur in sporadic cases.

Axial DWI MR in a different patient with vCJD shows diffusion restriction in bilateral posterior aspect of thalami in pulvinar region indicating pulvinar sign  . These signs are more common in vCJD but can occur in sporadic cases. Axial DWI MR in a different patient with vCJD shows diffusion restriction in bilateral posterior aspect of thalami in pulvinar region indicating pulvinar sign . These signs are more common in vCJD but can occur in sporadic cases.

Axial DWI MR in a patient with sCJD shows typical bilateral asymmetric (right > > left) cortical diffusion restriction  with sparing of perirolandic cortex . Axial DWI MR in a patient with sCJD shows typical bilateral asymmetric (right > > left) cortical diffusion restriction with sparing of perirolandic cortex .

Axial DWI MR in a patient with sCJD shows typical bilateral asymmetric (right > > left) cortical diffusion restriction  with sparing of perirolandic cortex . Axial DWI MR in a patient with sCJD shows typical bilateral asymmetric (right > > left) cortical diffusion restriction with sparing of perirolandic cortex .

Axial DWI MR of a 59-year-old woman patient with rapidly progressive dementia and myoclonus demonstrates asymmetric patchy cortical restricted diffusion (cortical ribbon sign)  in cingulate gyri and frontal lobe. EEG showed periodic sharp wave complexes. Axial DWI MR of a 59-year-old woman patient with rapidly progressive dementia and myoclonus demonstrates asymmetric patchy cortical restricted diffusion (cortical ribbon sign) in cingulate gyri and frontal lobe. EEG showed periodic sharp wave complexes.

Axial DWI MR of a 59-year-old woman patient with rapidly progressive dementia and myoclonus demonstrates asymmetric patchy cortical restricted diffusion (cortical ribbon sign)  in cingulate gyri and frontal lobe. EEG showed periodic sharp wave complexes. Axial DWI MR of a 59-year-old woman patient with rapidly progressive dementia and myoclonus demonstrates asymmetric patchy cortical restricted diffusion (cortical ribbon sign) in cingulate gyri and frontal lobe. EEG showed periodic sharp wave complexes.

Axial DWI MR in a patient with sCJD shows asymmetric diffusion restriction in right BG  and cortex . Axial DWI MR in a patient with sCJD shows asymmetric diffusion restriction in right BG and cortex .

Axial DWI MR in a patient with sCJD shows asymmetric diffusion restriction in right BG  and cortex . Axial DWI MR in a patient with sCJD shows asymmetric diffusion restriction in right BG and cortex .

Axial DWI MR of a 61-year-old woman patient with sCJD 'Heidenhain clinical phenotype presenting with visual hallucination and optical distortion is shown. Image demonstrates cortical restricted diffusion in bilateral occipital lobes . Axial DWI MR of a 61-year-old woman patient with sCJD 'Heidenhain clinical phenotype presenting with visual hallucination and optical distortion is shown. Image demonstrates cortical restricted diffusion in bilateral occipital lobes .

Axial DWI MR of a 61-year-old woman patient with sCJD 'Heidenhain clinical phenotype presenting with visual hallucination and optical distortion is shown. Image demonstrates cortical restricted diffusion in bilateral occipital lobes . Axial DWI MR of a 61-year-old woman patient with sCJD 'Heidenhain clinical phenotype presenting with visual hallucination and optical distortion is shown. Image demonstrates cortical restricted diffusion in bilateral occipital lobes .

Axial DWI MR of a 58-year-old man with rapidly progressive dementia, myoclonus, and ataxia due to sCJD demonstrates diffusion restriction involving the left cerebellum . Axial DWI MR of a 58-year-old man with rapidly progressive dementia, myoclonus, and ataxia due to sCJD demonstrates diffusion restriction involving the left cerebellum .

Axial DWI MR of a 58-year-old man with rapidly progressive dementia, myoclonus, and ataxia due to sCJD demonstrates diffusion restriction involving the left cerebellum . Axial DWI MR of a 58-year-old man with rapidly progressive dementia, myoclonus, and ataxia due to sCJD demonstrates diffusion restriction involving the left cerebellum .

Axial DWI MR through the vertex in the same patient shows involvement of perirolandic cortex on right . Typically the perirolandic cortex, cerebellum, and white matter are relatively spared in CJD. Axial DWI MR through the vertex in the same patient shows involvement of perirolandic cortex on right . Typically the perirolandic cortex, cerebellum, and white matter are relatively spared in CJD.

Axial DWI MR through the vertex in the same patient shows involvement of perirolandic cortex on right . Typically the perirolandic cortex, cerebellum, and white matter are relatively spared in CJD. Axial DWI MR through the vertex in the same patient shows involvement of perirolandic cortex on right . Typically the perirolandic cortex, cerebellum, and white matter are relatively spared in CJD.

Additional Images

Axial DWI MR in a different patient shows hyperintense signal consistent with restricted diffusion in right posterior temporal lobe and occipital lobe cortex. Axial DWI MR in a different patient shows hyperintense signal consistent with restricted diffusion in right posterior temporal lobe and occipital lobe cortex.

Axial DWI MR in a different patient shows hyperintense signal consistent with restricted diffusion in right posterior temporal lobe and occipital lobe cortex. Axial DWI MR in a different patient shows hyperintense signal consistent with restricted diffusion in right posterior temporal lobe and occipital lobe cortex.

Axial DWI MR shows hyperintense signal consistent with restricted diffusion within both amygdalae. Axial DWI MR shows hyperintense signal consistent with restricted diffusion within both amygdalae.

Axial DWI MR shows hyperintense signal consistent with restricted diffusion within both amygdalae. Axial DWI MR shows hyperintense signal consistent with restricted diffusion within both amygdalae.

Axial DWI MR demonstrates bright signal of restricted diffusion in bodies of both caudate nuclei. Axial DWI MR demonstrates bright signal of restricted diffusion in bodies of both caudate nuclei.

Axial DWI MR demonstrates bright signal of restricted diffusion in bodies of both caudate nuclei. Axial DWI MR demonstrates bright signal of restricted diffusion in bodies of both caudate nuclei.

Axial FLAIR MR shows bilateral hyperintense signal in putamina and thalami from CJD. Axial FLAIR MR shows bilateral hyperintense signal in putamina and thalami from CJD.

Axial FLAIR MR shows bilateral hyperintense signal in putamina and thalami from CJD. Axial FLAIR MR shows bilateral hyperintense signal in putamina and thalami from CJD.

Coronal FLAIR MR in the same patient with CJD demonstrates hyperintense signal in both thalami. Coronal FLAIR MR in the same patient with CJD demonstrates hyperintense signal in both thalami.

Coronal FLAIR MR in the same patient with CJD demonstrates hyperintense signal in both thalami. Coronal FLAIR MR in the same patient with CJD demonstrates hyperintense signal in both thalami.

Coronal FLAIR MR shows hyperintense signal in caudate nuclei, lentiform nuclei, and within temporal lobe cortices and hippocampi. Coronal FLAIR MR shows hyperintense signal in caudate nuclei, lentiform nuclei, and within temporal lobe cortices and hippocampi.

Coronal FLAIR MR shows hyperintense signal in caudate nuclei, lentiform nuclei, and within temporal lobe cortices and hippocampi. Coronal FLAIR MR shows hyperintense signal in caudate nuclei, lentiform nuclei, and within temporal lobe cortices and hippocampi.

Axial DWI MR shows bilateral restricted diffusion in the putamen and caudate nuclei with small foci in thalami. Axial DWI MR shows bilateral restricted diffusion in the putamen and caudate nuclei with small foci in thalami.

Axial DWI MR shows bilateral restricted diffusion in the putamen and caudate nuclei with small foci in thalami. Axial DWI MR shows bilateral restricted diffusion in the putamen and caudate nuclei with small foci in thalami.

Axial T2WI MR shows bilateral increased signal intensity in putamen and caudate nuclei in a patient with CJD. Axial T2WI MR shows bilateral increased signal intensity in putamen and caudate nuclei in a patient with CJD.

Axial T2WI MR shows bilateral increased signal intensity in putamen and caudate nuclei in a patient with CJD. Axial T2WI MR shows bilateral increased signal intensity in putamen and caudate nuclei in a patient with CJD.

Axial FLAIR MR shows symmetric hyperintensity in the caudate and putamen, characteristic of sCJD. sCJD is the most common type of CJD, representing 85% of cases. Axial FLAIR MR shows symmetric hyperintensity in the caudate and putamen, characteristic of sCJD. sCJD is the most common type of CJD, representing 85% of cases.

Axial FLAIR MR shows symmetric hyperintensity in the caudate and putamen, characteristic of sCJD. sCJD is the most common type of CJD, representing 85% of cases. Axial FLAIR MR shows symmetric hyperintensity in the caudate and putamen, characteristic of sCJD. sCJD is the most common type of CJD, representing 85% of cases.

Axial DWI MR shows asymmetric diffusion restriction in the caudate nuclei and putamen. Involvement of the anterior more than the posterior putamen is typical of CJD. There is also asymmetric hyperintensity in the frontal and temporal lobe cortical ribbons , typical of sCJD. (Courtesy N. Fischbein, MD.) Axial DWI MR shows asymmetric diffusion restriction in the caudate nuclei and putamen. Involvement of the anterior more than the posterior putamen is typical of CJD. There is also asymmetric hyperintensity in the frontal and temporal lobe cortical ribbons , typical of sCJD. (Courtesy N. Fischbein, MD.)

Axial DWI MR shows asymmetric diffusion restriction in the caudate nuclei and putamen. Involvement of the anterior more than the posterior putamen is typical of CJD. There is also asymmetric hyperintensity in the frontal and temporal lobe cortical ribbons , typical of sCJD. (Courtesy N. Fischbein, MD.) Axial DWI MR shows asymmetric diffusion restriction in the caudate nuclei and putamen. Involvement of the anterior more than the posterior putamen is typical of CJD. There is also asymmetric hyperintensity in the frontal and temporal lobe cortical ribbons , typical of sCJD. (Courtesy N. Fischbein, MD.)

Axial DWI MR shows classic sCJD with diffusion restriction in the caudate and putamen as well as throughout the cortex. Frontal, temporal, and parietal cortical involvement is most common. Relative sparing of the pre- and postcentral gyri is typical of CJD. Axial DWI MR shows classic sCJD with diffusion restriction in the caudate and putamen as well as throughout the cortex. Frontal, temporal, and parietal cortical involvement is most common. Relative sparing of the pre- and postcentral gyri is typical of CJD.

Axial DWI MR shows classic sCJD with diffusion restriction in the caudate and putamen as well as throughout the cortex. Frontal, temporal, and parietal cortical involvement is most common. Relative sparing of the pre- and postcentral gyri is typical of CJD. Axial DWI MR shows classic sCJD with diffusion restriction in the caudate and putamen as well as throughout the cortex. Frontal, temporal, and parietal cortical involvement is most common. Relative sparing of the pre- and postcentral gyri is typical of CJD.

Axial FLAIR MR shows bilateral, symmetric hyperintensities in the posterior thalami representing the "pulvinar" sign, which is characteristic of vCJD. Another "pulvinar" sign is the T1 shortening seen in Fabry disease. Axial FLAIR MR shows bilateral, symmetric hyperintensities in the posterior thalami representing the "pulvinar" sign, which is characteristic of vCJD. Another "pulvinar" sign is the T1 shortening seen in Fabry disease.

Axial FLAIR MR shows bilateral, symmetric hyperintensities in the posterior thalami representing the "pulvinar" sign, which is characteristic of vCJD. Another "pulvinar" sign is the T1 shortening seen in Fabry disease. Axial FLAIR MR shows bilateral, symmetric hyperintensities in the posterior thalami representing the "pulvinar" sign, which is characteristic of vCJD. Another "pulvinar" sign is the T1 shortening seen in Fabry disease.

Axial DWI MR shows symmetric hyperintensity in the BG and thalami bilaterally. The thalamic involvement shows the "hockey stick" sign, which is symmetric pulvinar and dorsomedial thalamus hyperintensity. This sign is most commonly seen in vCJD but may also be present in sCJD, as in this case. Axial DWI MR shows symmetric hyperintensity in the BG and thalami bilaterally. The thalamic involvement shows the "hockey stick" sign, which is symmetric pulvinar and dorsomedial thalamus hyperintensity. This sign is most commonly seen in vCJD but may also be present in sCJD, as in this case.

Axial DWI MR shows symmetric hyperintensity in the BG and thalami bilaterally. The thalamic involvement shows the "hockey stick" sign, which is symmetric pulvinar and dorsomedial thalamus hyperintensity. This sign is most commonly seen in vCJD but may also be present in sCJD, as in this case. Axial DWI MR shows symmetric hyperintensity in the BG and thalami bilaterally. The thalamic involvement shows the "hockey stick" sign, which is symmetric pulvinar and dorsomedial thalamus hyperintensity. This sign is most commonly seen in vCJD but may also be present in sCJD, as in this case.